+Search query
-Structure paper
| Title | XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. |
|---|---|
| Journal, issue, pages | J Immunother Cancer, Vol. 11, Year 2023 |
| Publish date | Feb 5, 2023 (structure data deposition date) |
Authors | Jenkins, K.A. / Park, M. / Pederzoli-Ribeil, M. / Eskiocak, U. / Johnson, P. / Guzman, W. / McLaughlin, M. / Moore-Lai, D. / O'Toole, C. / Liu, Z. ...Jenkins, K.A. / Park, M. / Pederzoli-Ribeil, M. / Eskiocak, U. / Johnson, P. / Guzman, W. / McLaughlin, M. / Moore-Lai, D. / O'Toole, C. / Liu, Z. / Nicholson, B. / Flesch, V. / Qiu, H. / Clackson, T. / O'Hagan, R.C. / Rodeck, U. / Karow, M. / O'Neil, J. / Williams, J.C. |
External links | J Immunother Cancer / PubMed:38164757 |
| Methods | X-ray diffraction |
| Resolution | 1.8 - 3 Å |
| Structure data | ![]() PDB-8g2m: ![]() PDB-8g8n: |
| Chemicals | ![]() ChemComp-CIT: ![]() ChemComp-HOH: |
| Source |
|
Keywords | IMMUNE SYSTEM / Engineered antibody / Anti-CTLA4 mAb |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links




homo sapiens (human)
Keywords